三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
国内CTLA4相关标的、相关管线
国内CTLA4相关标的、相关管线
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:733KB
图片尺寸:2302*1897
同报告图片
/
4
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
所属报告:
医药生物行业CTLA4专题:技术革新来临聚焦“增效减毒”的新一代疗法投资机遇-251222(18页).pdf
打包全文图表
相关数据
ONC-392与传统CTLA-4单抗对比(机制、疗效、安全性)
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
收藏
行业数据
2025-12-24
原图定位
查看详情
2019-2035E全球CTLA-4抗体药物市场(亿美元)
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
收藏
行业数据
2025-12-22
原图定位
查看详情
全球(中国除外)CTLA-4靶向双抗/双功能融合蛋白管线竞争格局(截至2025
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
收藏
竞争格局
2025-12-22
原图定位
查看详情
2019-2035E全球CTLA-4抗体药物市场(亿美元)
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
收藏
行业数据
2025-12-19
原图定位
查看详情
全球(中国除外)CTLA-4靶向双抗/双功能融合蛋白管线竞争格局(截至2025
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
收藏
竞争格局
2025-12-19
原图定位
查看详情
开坦尼®(卡度尼利,PD-1/CTLA-4)临床研究计划
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
收藏
其它
2024-07-10
原图定位
查看详情
AK104治疗末线宫颈癌对比PD-1单药或PD-1+CTLA4联合疗法明显提升疗效
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
收藏
其它
2024-06-25
原图定位
查看详情
全球临床阶段PD-(L)1×CTLA-4双抗竞争格局
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
收藏
竞争格局
2024-04-12
原图定位
查看详情
表26、中国PD-(L)1/CTLA-4双抗研发格局
5Lul5LiL5piv5qC55o2u5oKo5o+Q5L6b55qE5Zu+54mH5YaF5a6555Sf5oiQ55qE5pWw5o2u6KGo5qC877yaCgp8IOiNr+eJqSAgICAgICAgICB8IOWFrOWPuCAgICAgICAgIHwg6Z2254K5ICAgICAgIHwg6YCC5bqU55eHICB8IOmYtuautSAgfCDpppbmrKHlhazluIPml7bpl7QgfAp8LS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS18LS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwKfCDljaHluqblsLzliKnljZXmipcgIHwg5bq35pa555Sf54mpICAgICB8IENUTEE0L1BEMSAgfCDlrqvpoojnmYwgICB8IOiOt+aJuSAgfCAyMDIyLTYgICAgICAgfAp8ICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgfCAgICAgICAgICAgIHwg6IOD55mMICAgIHwgM+acnyAgIHwgMjAyMS03ICAgICAgIHwKfCAgICAgICAgICAgICAgIHwgICAgICAgICAgICAgIHwgICAgICAgICAgICB8IE5TQ0xDICAgfCAz5pyfICAgfCAyMDIzLTcgICAgICAgfAp8IGVyZm9ucmlsaW1hYiAgfCDlurflroHmnbDnkZ4gICAgIHwgQ1RMQTQvUERMMSB8IE5TQ0xDICAgfCAz5pyfICAgfCAyMDIwLTcgICAgICAgfAp8ICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgfCAgICAgICAgICAgIHwg6IOw6IW655mMICAgfCAz5pyfICAgfCAyMDIxLTEyICAgICAgfAp8IHZvbHJ1c3RvbWlnICAgfCDpmL/mlq/liKnlurcgICAgIHwgQ1RMQTQvUEQxICB8IE5TQ0xDICAgfCAz5pyfICAgfCAyMDIzLTggICAgICAgfAp8ICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgfCAgICAgICAgICAgIHwg6IOD55mMICAgIHwgMuacnyAgIHwgMjAyMC01ICAgICAgIHwKfCBTSS1CMDAzICAgICAgIHwgU3lzdGltbXVuZSAgIHwgQ1RMQTQvUEQxICB8IE5TQ0xDICAgfCAy5pyfICAgfCAyMDIzLTcgICAgICAgfAp8ICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgfCAgICAgICAgICAgIHwg6IOD55mMICAgIHwgMuacnyAgIHwgMjAyMC04ICAgICAgIHwKfCBTS0IzMzcgICAgICAgIHwg56eR5Lym5Y2a5rOwICAgICB8IENUTEE0L1BETDEgfCDlrp7kvZPnmKQgICB8IDHmnJ8gICB8IDIwMjEtNSAgICAgICB8CgrotYTmlpnmnaXmupDvvJrljLvoja/prZTmlrnvvIzlhbTkuJror4HliLjnu4/mtY7kuI7ph5Hono3noJTnqbbpmaLmlbTnkIY=
收藏
其它
2023-12-06
原图定位
查看详情
全球CTLA-4靶点开发适应症布局情况
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
收藏
行业数据
2023-07-03
原图定位
查看详情
表4.全球PD-(L)1/CTLA-4双抗研发进展
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
收藏
行业数据
2023-06-12
原图定位
查看详情
中国在研PD-1和CTLA-4联合疗法市场竞争格局
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
收藏
行业数据
2023-05-31
原图定位
查看详情
国内PD-1/CTLA-4双抗领域竞争格局
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
收藏
行业数据
2023-03-23
原图定位
查看详情
PD-(L)1/CTLA-4双抗全球研发进展
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
收藏
行业数据
2023-02-10
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
在国内,多家生物技术公司基于相似逻辑(如增强靶向性、降低毒性)开发了各有特色的 CTLA-4靶向药物。如和铂医药的 HBM4003(全人源重链抗体)、天演药业的 ADG126(前体抗体技术)、康方生物的 AK104(PD-1/CTLA-4 双特异性抗体)、宜明昂科的 IMM27M(Fc 端改造增强ADCC效应)、礼新医药/中国生物制药的 LM-168(靶向肿瘤微环境)、基石药业 CS2009(CTLA-4低亲和力实现减毒增效)。
行业数据
原图定位
当前图表所属:
医药生物行业CTLA4专题:技术革新来临聚焦“增效减毒”的新一代疗法投资机遇-251222(18页).pdf
2026年医药生物行业周报:CTLA4三期OS率翻倍,创新药与CXO趋势分析
医药生物行业CTLA4专题:技术革新来临聚焦“增效减毒”的新一代疗法投资机遇-251222
中泰医药重点推荐本周表现
医药板块本周个股跌幅榜(扣除ST股)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》